Masimo O3 Regional Oximeter System
Oximeter, Tissue Saturation. 510(k) K160526, from Masimo Corporation (Irvine, CA). Product code MUD, class 2.
As of Nov 21, 2026, K160526 is an FDA 510(k) held by Masimo Corporation, substantially equivalent on Jun 9, 2016 after 105 days, with no recalls tied to it in FDA's recall database.
- Review time: 105 days
- Recalls: 0
- Cited as a predicate by: 2 devices
The noninvasive Masimo O3 Regional Oximeter System and accessories are intended for use as an adjunct monitor of absolute and trended regional hemoglobin oxygen saturation of blood (rSO2) in the cerebral region under the sensors 7KH0DVLPR25HJLRQDO2[LPHWHU6\VWHPDQGDFFHVVRULHVDUHLQGLFDWHGIRUXVHRQDGXOWVNJLQKHDOWKFDUH HQYLURQPHQWV
- Fore-Sight Elite Absolute Tissue OximeterK133879 · Cas Medical Systems, Inc. · Apr 29, 2014
- Masimo O3 Regional Oximeter SystemK182429 · Masimo Corporation · Jun 7, 2019
- Masimo O3 Regional Oximeter SystemK162603 · Masimo Corporation · May 26, 2017
- OxySight for MolecuLightDX+K262858 · MolecuLight, Inc. · Nov 5, 2026
- Spectrum-2K254129 · Neko Health AB · May 22, 2026
- Masimo O3 Regional OximeterK243324 · Masimo Corporation · Jul 17, 2025
- Lap.Ox™ Laparoscopic Tissue OximeterK250519 · ViOptix, Inc. · Jun 26, 2025
- Cerebral Autoregulation Index (CAI) AlgorithmK240596 · Edwards Lifesciences · Oct 16, 2024
- ODI-TechK241393 · Odi Medical AS · Aug 30, 2024
- SnapshotNIR model KD205K240601 · Kent Imaging, Inc. · Apr 2, 2024
- OxiplexTS200K232385 · Iss Medical, Inc. · Mar 1, 2024
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Feb 25, 2016
- Review panel
- Cardiovascular
- Regulation
- 21 CFR 870.2700
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files